AMC Cancer Institute was visited by 1,120,108 patients in 2022. Of these, 1,039,867 were outpatients and 80,241 were inpatients. The total number of cancer patients recorded more than 1 million for the past three consecutive years, with 1,120,108 in 2022, 1,102,350 in 2021, and 1,037,050 in 2020.

Last year, 35,339 patients were newly diagnosed with cancer and registered as new patients, and 22,354 cancer surgeries were performed. The number of multidisciplinary clinics increased from 5,472 cases in 2021 to 6,189 in 2022, marking an increase of 13%. A multidisciplinary clinic is a medical service where multiple specialists from diverse departments gather to provide customized treatment for a cancer patient from diagnosis to surgery. Asan Medical Center was the first hospital in South Korea to launch the service in June 2006.

The number of next-generation sequencing (NGS) genetic testing performed was 5,232, and 22,477 cases of specialized cancer treatment and cancer patient QoL (quality of life) management were carried out. In addition, 218,676 cases of chemotherapy and 113,430 cases of radiotherapy were conducted.

Medical specialists at AMC Cancer Institute published 494 papers in 2022. Among these, 36 were published in journals with an impact factor of 20 or above, such as Lancet Oncology and JAMA Oncology, considered the world’s top academic journals in clinical oncology. Cancer-related clinical trials amounted to 529 cases.